Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mara Roth

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Laryngoscope|June 24, 2026
Thyroid Cartilage Reconstruction With Titanium Mesh in Advanced Papillary Thyroid CarcinomaAnna Christina Clements, Cassie Pan, Neel K Bhatt, et al.
Plos One|June 30, 2017
A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodineLaura Q Chow, Rafael Santana-Davila, Austin Pantel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
QIM26-313: Improving Molecular Testing Rates in Advanced Thyroid Cancer Through a Standardized Testing PathwayLauren Shih, Perrin Romine, Mara Roth, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
QIM26-313: Improving Molecular Testing Rates in Advanced Thyroid Cancer Through a Standardized Testing PathwayLauren Shih, Perrin Romine, Mara Roth, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Laryngoscope|June 24, 2026
Thyroid Cartilage Reconstruction With Titanium Mesh in Advanced Papillary Thyroid CarcinomaAnna Christina Clements, Cassie Pan, Neel K Bhatt, et al.
Plos One|June 30, 2017
A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodineLaura Q Chow, Rafael Santana-Davila, Austin Pantel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
QIM26-313: Improving Molecular Testing Rates in Advanced Thyroid Cancer Through a Standardized Testing PathwayLauren Shih, Perrin Romine, Mara Roth, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
QIM26-313: Improving Molecular Testing Rates in Advanced Thyroid Cancer Through a Standardized Testing PathwayLauren Shih, Perrin Romine, Mara Roth, et al.
Pageof 1